Skip to content
healthcare.dev

Xlear Nasal Decongestant

NDC 27017-018, Nasal Spray, liquid, from Xlear Inc..

Product NDC
27017-018
Status
Listed
Labeler
Xlear Inc.
Dosage form
LIQUID
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27017-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYMETAZOLINE HYDROCHLORIDE.0005 g/g

Pharmacologic classes

Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]

Package NDCNDC-11Package
27017-018-01270170018011 g in 1 BOTTLE, SPRAY (27017-018-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 27017-018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27017-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27017-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.